Page 201 - Vitamin D and Cancer

188 S.A. Mazzilli et al.

11. Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signaling pathways in cancer: potential
for anticancer therapeutics. Nat Rev Cancer 7:684–700
12. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D (1994)
Antiproliferative effects of 1, 25-dihydroxyvitamin D on primary cultures of human prostatic
3
cells. Cancer Res 54:805–810
13. Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Uskokovic MR, Brenner RV,
Evans SR (1994) Growth inhibition of HT-29 human colon cancer cells by analogues of 1,
25-dihydroxyvitamin D . Cancer Res 54:4057–4064
3
14. Anzano MA, Smith JM, Uskokovic MR, Peer CW, Mullen LT, Letterio JJ, Welsh MC, Shrader
MW, Logsdon DL, Driver CL et al (1994) 1 alpha, 25-Dihydroxy-16-ene-23-yne-26, 27-hexaflu-
orocholecalciferol (Ro24–5531), a new deltanoid (vitamin D analogue) for prevention of breast
cancer in the rat. Cancer Res 54:1653–1656
15. Lipkin M, Yang K, Edelmann W, Xue L, Fan K, Risio M, Newmark H, Kucherlapati R (1999)
Preclinical mouse models for cancer chemoprevention studies. Ann N Y Acad Sci
889:14–19
16. Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M (2009) Western-style
diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice:
a preclinical model for human sporadic colon cancer. Carcinogenesis 30:88–92
17. Yang K, Edelmann W, Fan K, Lau K, Leung D, Newmark H, Kucherlapati R, Lipkin M (1998)
Dietary modulation of carcinoma development in a mouse model for human familial adenom-
atous polyposis. Cancer Res 58:5713–5717
18. Banach-Petrosky W (2006) Vitamin D inhibits the formation of prostatic intraepithelial neo-
plasia in Nkx3.1;Pten mutant mice. Clinical Cancer Research 12;5895
19. Tangpricha V, Spina C, Yao M, Chen TC, Wolfe MM, Holick MF (2005) Vitamin D defi-
ciency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J Nutr
135:2350–2354
20. Fichera A, Little N, Dougherty U, Mustafi R, Cerda S, Li YC, Delgado J, Arora A, Campbell
LK, Joseph L, Hart J, Noffsinger A, Bissonnette M (2007) A vitamin D analogue inhibits
colonic carcinogenesis in the AOM/DSS model. J Surg Res 142:239–245
21. Kallay E, Bareis P, Bajna E, Kriwanek S, Bonner E, Toyokuni S, Cross HS (2002) Vitamin D
receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem
Toxicol 40:1191–1196
22. Perez-Stable CM, Schwartz GG, Farinas A, Finegold M, Binderup L, Howard GA, Roos BA
(2002) The G gamma/T-15 transgenic mouse model of androgen-independent prostate cancer:
target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089. Cancer
Epidemiol Biomarkers Prev 11:555–563
23. Jacobson EA, James KA, Newmark HL, Carroll KK (1989) Effects of dietary fat, calcium,
and vitamin D on growth and mammary tumorigenesis induced by 7, 12-dimethylbenz(a)
anthracene in female Sprague-Dawley rats. Cancer Res 49:6300–6303
24. Xue L, Newmark H, Yang K, Lipkin M (1996) Model of mouse mammary gland hyperprolif-
eration and hyperplasia induced by a western-style diet. Nutr Cancer 26:281–287
25. Moon RC, Thompson HJ, Becci PJ, Grubbs CJ, Gander RJ, Newton DL, Smith JM,
Phillips SL, Henderson WR, Mullen LT, Brown CC, Sporn MB (1979) N-(4-hydroxyphenyl)
retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res
39:1339–1346
26. Murillo G, Mehta RG (2005) Chemoprevention of chemically-induced mammary and colon
carcinogenesis by 1alpha-hydroxyvitamin D5. J Steroid Biochem Mol Biol 97:129–136
27. Zinser G, Packman K, Welsh J (2002) Vitamin D(3) receptor ablation alters mammary gland
morphogenesis. Development 129:3067–3076
28. Mernitz H, Smith DE, Wood RJ, Russell RM, Wang XD (2007) Inhibition of lung carcinogen-
esis by 1alpha, 25-dihydroxyvitamin D and 9-cis retinoic acid in the A/J mouse model:
3
evidence of retinoid mitigation of vitamin D toxicity. Int J Cancer 120:1402–1409
29. Nakagawa K, Kawaura A, Kato S, Takeda E, Okano T (2005) 1 alpha, 25-Dihydroxyvitamin
D(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis 26:429–440